QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=B82CADF74A786F89E0B89C919FA4EC99;jsessionid=79E378C1DD5056CF57AEA2EFF8657F46;jsessionid=63B3A212E46DFE21038AC69D13A81BBA;jsessionid=B9A0EB3BCC73C4A3659E5DB55B6FAF95;jsessionid=BA79B857C2820389AFD3358E6E0BF968 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=B82CADF74A786F89E0B89C919FA4EC99;jsessionid=79E378C1DD5056CF57AEA2EFF8657F46;jsessionid=63B3A212E46DFE21038AC69D13A81BBA;jsessionid=B9A0EB3BCC73C4A3659E5DB55B6FAF95;jsessionid=BA79B857C2820389AFD3358E6E0BF968